Active Ingredient(s):Apalutamide FDA Approved: * February 14, 2018 Pharm Company: *JANSSEN BIOTECH Category:Cancer
Apalutamide, sold under the brand name Erleada among others, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. It is specifically indicated for use in conjunction with castration in the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC). It is taken by mouth.[2&...
* May have multiple approval dates, manufacturers, or labelers.